In the last trading session, 1.5 million shares of the Perspective Therapeutics Inc (AMEX:CATX) were traded, and its beta was 1.31. Most recently the company’s share price was $6.96, and it changed around -$0.92 or -11.68% from the last close, which brings the market valuation of the company to $415.56M. CATX currently trades at a discount to its 52-week high of $19.05, offering almost -173.71% off that amount. The share price’s 52-week low was $2.28, which indicates that the current value has risen by an impressive 67.24% since then. We note from Perspective Therapeutics Inc’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 914.31K.
Perspective Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended CATX as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight. Perspective Therapeutics Inc is expected to report earnings per share of -0.25 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Perspective Therapeutics Inc (AMEX:CATX) trade information
Instantly CATX has showed a red trend with a performance of -11.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 11.17 on recent trading dayincreased the stock’s daily price by 37.69%. The company’s shares are currently up 73.13% year-to-date, but still down -37.24% over the last five days. On the other hand, Perspective Therapeutics Inc (AMEX:CATX) is -44.98% down in the 30-day period. We can see from the shorts that 8.02 million shares have been sold at a short interest cover period of 9.06 day(s).
The consensus price target as assigned by Wall Street analysts is $21, which translates to bulls needing to increase their stock price by 66.86% from its current value. Analyst projections state that CATX is forecast to be at a low of $3 and a high of $24.
Perspective Therapeutics Inc (CATX) estimates and forecasts
Perspective Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -57.30 percent over the past six months and at a 34.29% annual growth rate that is well above the industry average of 15.60%. The year-over-year growth rate is expected to be -5.44%, down from the previous year.
Consensus estimates provided by 10 financial analysts predict the company will bring in an average of 232.76k in revenue for the current quarter. 4 analysts expect Perspective Therapeutics Inc to make 151.33k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were -4.9M and 325k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 104.75%. Forecasts for the next quarter put sales growth at -53.44%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -7.69%.
CATX Dividends
Perspective Therapeutics Inc’s next quarterly earnings report is expected to be released in December.
Perspective Therapeutics Inc (AMEX:CATX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 20.43% of Perspective Therapeutics Inc shares, and 81.30% of them are in the hands of institutional investors. The stock currently has a share float of 102.17%.
